Collegium Announces $50M Accelerated Share Repurchase Program
Portfolio Pulse from Benzinga Newsdesk
Collegium Pharmaceutical, Inc. has announced a $50 million accelerated share repurchase (ASR) program. The ASR is expected to be funded from the company's existing cash on hand.

August 07, 2023 | 11:33 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Collegium's announcement of a $50M ASR program could potentially boost investor confidence and increase the stock's demand, leading to a short-term increase in its price.
Accelerated share repurchase programs are often seen as a sign of a company's confidence in its own stock. By buying back its own shares, Collegium is reducing the number of shares available in the market, which could increase the stock's price due to the increased demand. Furthermore, the fact that the ASR is being funded from existing cash suggests that the company is in a strong financial position.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100